Lannett Company, Inc.
$0.69▲ 0.00%(+$0.00)
TickerSpark Score
48/100
▌ Weak
100
Valuation
45
Profitability
10
Growth
56
Health
30
Momentum
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LCI research report →
52-Week Range18% of range
Low
$0.01
Current
$0.69
High
$3.72
Company Overviewwww.lannett.com
About the company
Lannett Company, Inc. operates as a U. S.
- CEO
- Timothy C. Crew
- IPO
- 2013
- Employees
- 564
- HQ
- Trevose, PA, US
Price Chart
-98.62% · this period
Valuation
- Market Cap
- $7.38M
- P/E
- -0.03
- P/S
- 0.02
- P/B
- -0.03
- EV/EBITDA
- -4.64
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 9.74%
- Op Margin
- -20.62%
- Net Margin
- -68.01%
- ROE
- 166.31%
- ROIC
- -18.22%
Growth & Income
- Revenue
- $340.58M · -28.86%
- Net Income
- $-231,620,000 · 36.28%
- EPS
- $-22.96 · -902.62%
- Op Income
- $-70,219,000
- FCF YoY
- -138.34%
Performance & Tape
- 52W High
- $3.72
- 52W Low
- $0.01
- 50D MA
- $1.30
- 200D MA
- $2.00
- Beta
- 0.95
- Avg Volume
- 208.27K
Get TickerSpark's AI analysis on LCI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Form 4 · Filings
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 17, 22 | Chapman John C | buy | 20,000 |
| Nov 10, 22 | LEPORE PATRICK G | buy | 100,000 |
| Nov 10, 22 | Crew Timothy C | buy | 15,000 |
| Sep 14, 22 | Rewolinski Melissa | buy | 31,159 |
| Sep 7, 22 | KOZLOWSKI JOHN | other | 775 |
| Sep 7, 22 | Abt John | other | 950 |
| Jul 29, 22 | Abt John | other | 3,924 |
| Jul 29, 22 | Cavanaugh Maureen | other | 5,656 |
| Jul 29, 22 | Crew Timothy C | other | 19,368 |
| Jul 29, 22 | Israel Samuel H | other | 10,154 |
Coverage · LCI
Our LCI coverage
Recent articles, reports, and earnings notes.
On-Demand Research
No research on LCI yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate LCI report →Internal Compare
Similar companies
Peers in the same neighborhood.
DMKPQ▲0.00%
DMK Pharmaceuticals Corporation
$0.00
NLTX▲1.45%
Neoleukin Therapeutics, Inc.
$3.49
HLTHQ▲0.00%
Cue Health Inc.
$0.00
MODV▲0.00%
ModivCare Inc.
$0.43
STRR▲2.42%
Star Equity Holdings, Inc.
$10.99
OMGA▲0.00%
Omega Therapeutics, Inc.
$0.14
FRTX▼0.53%
Fresh Tracks Therapeutics, Inc.
$0.94
KA▼30.77%
Kineta, Inc.
$0.57